NASDAQ:ATRA

Atara Biotherapeutics Stock Predictions

etoro logo Buy ATRA
*Your capital is at risk
$9.63
-0.270 (-2.73%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ATRA Prediction Chart

ATRA Predictions History

Latest community submissions for ATRA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 21, 2025 $9.77 -2.33% $11.50 X 84.93% 0
Jul 21, 2025 $9.85 -1.45% $11.50 X 85.69% 0
Jul 21, 2025 $12.59 +25.90% $11.50 V 90.52% 1
Jan 17, 2025 $8.71 +11.23% $6.57 X 67.44% 0
Jan 17, 2025 $8.38 +7.02% $6.57 X 72.46% 0
Jan 17, 2025 $6.71 -49.01% $6.57 V 97.87% 1
Jan 31, 2024 $0.592 -96.18% $0.624 V 94.88% 0
Jan 31, 2024 $0.602 -96.11% $0.624 V 96.58% 0
Jan 31, 2024 Bullish $0.624 X 1
Jul 7, 2021 Bearish $14.59 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ATARA BIOTHERAPEUTICS
Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE